Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
5,800
Employees5,800
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
5,800
Employees5,800

MRNA Key Statistics

Market cap
13.01B
Market cap13.01B
Price-Earnings ratio
-3.86
Price-Earnings ratio-3.86
Dividend yield
Dividend yield
Average volume
11.39M
Average volume11.39M
High today
$34.49
High today$34.49
Low today
$33.22
Low today$33.22
Open price
$34.04
Open price$34.04
Volume
6.92M
Volume6.92M
52 Week high
$129.39
52 Week high$129.39
52 Week low
$23.15
52 Week low$23.15

MRNA News

Simply Wall St 22h
Moderna (NasdaqGS:MRNA) Added to Russell Midcap Indexes

recently experienced significant index changes, with the company being added to the Russell Midcap and Midcap Value indexes, while being dropped from several ot...

Moderna (NasdaqGS:MRNA) Added to Russell Midcap Indexes
TipRanks 3d
Moderately bullish activity in Moderna with shares up 3.95%

Moderately bullish activity in Moderna (MRNA), with shares up $1.29, or 3.95%, near $34.09. Options volume relatively light with 51k contracts traded and calls...

Benzinga 3d
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s MRNA supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID...

FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

Analyst ratings

64%

of 28 ratings
Buy
21.4%
Hold
64.3%
Sell
14.3%

More MRNA News

Seeking Alpha 3d
Moderna wins full FDA approval for COVID shot in children

Moderna (NASDAQ:MRNA) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its Spikevax COVID-19 vaccine to all...

Moderna wins full FDA approval for COVID shot in children
Sherwood News 5d
Moderna rises, reaching highest price since March

Moderna rises, reaching highest price since March Moderna is up more than 11% on seemingly no news beyond positive trial data for its experimental flu vaccine...

Moderna rises, reaching highest price since March

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.